Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis: Randomised Placebo-Controlled Trial
Lancet 364:1149-1156, Hommes,O.R.,et al, 2004
The Bioavailability of IV Methylprednisolone and Oral Prednisone in Multiple Sclerosis
Neurol 63:1079-1080, Morrow,S.A.,et al, 2004
The MATCH Study Results in the Context of Secondary Stroke Prevention
Stroke 35:2609, Fisher,M. &Davalos,A., 2004
Thoughts Evoked by MATCH and Other Trials
Stroke 35:2604-2605, Caplan,L.R., 2004
The United Kingdom Infantile Spasms Study Comparing Vigabatrin with Prednisolone or Tetracosactide at 14 Days: A Multicentre, Randomised Controlled Trial
Lancet 364:1773-1778, Lux,A.L.,et al, 2004
Early Epidural Blood Patch in Spontaneous Intracranial Hypotension
Neurol 63:1950-1951, Berroir,S.,et al, 2004
Interferon beta-1b in Secondary Progressive MS
Neurol 63:1779-1787,1768, Kappos,L.,et al, 2004
Interferon beta-1b in Secondary Progressive MS
Neurol 63:1788-1795,1768, The North American Study Group on Interferon beta-, 2004
Guillain-Barre Syndrome Follwoing Influenza Vaccination
JAMA 292:2478-2481, Haber,P.,et al, 2004
In-Hospital Initiation of Secondary Stroke Prevention Therapies Yields High Rates of Adherence at Follow-up
Stroke 35:2879-2883, Ovbiagele,B.,et al, 2004
Statins in Stroke Prevention and Carotid Artherosclerosis, Systematic Review and Up-to-Date Meta-Analysis
Stroke 35:2902-2909, Amarenco,P.,et al, 2004
IV Immunoglobulins as Add-on Treatment to Methylprednisolone for Acute Relapses in MS
Neurol 63:2028-2033, Sorensen,P.S.,et al, 2004
Normal Intelligence in Children with Prenatal Exposure to Carbamazepine
Neurol 62:28-32,8, Gaily,E.,et al, 2004
Systematic Screening Allows Reduction of Adverse Antiepileptic Drug Effects
Neurol 62:23-27, Gilliam,F.G.,et al, 2004
Mitoxantrone for Multiple Sclerosis in Clinical Practice
Neurol 63(Suppl 6):S25-S27, Rizvi,S.A.,et al, 2004
Mitoxantrone Treatment of Multiple Sclerosis
Neurol 63(Suppl 6):S28-S32, Cohen,B.A. &Mikol,D.D., 2004
Parenteral Metoclopramide for Acute Migraine: Meta-Analysis of Randomised Controlled Trials
BMJ 329:1369-1372, Colman,I.,et al, 2004
Risk of Myocardial Infarction and Stroke after Acute Infection or Vaccination
NEJM 351:2611-2618, Smeeth,L.,et al, 2004
Practice Parameter: Pharmacological Treatment of Migraine Headache in Children and Adolescents
Neurol 63:2215-2224, Lewis,D.,et al, 2004
Migraine and Other Headaches
Neurol 63:2233-2239,2209, Rose,K.M.,et al, 2004
Approach to the Dilated Aortic Root
Curr Opin Cardiol 19:563-569, Boyer, J.K.,et al, 2004
Long Term Visual and Neurological Prognosis in Patients with Treated and Untreated Cavernous Sinus Aneurysms
JNNP 75:863-867, Goldenberg-Cohen, N.,et al, 2004
Idiopathic Generalized Epilepsy and Choice of Antiepileptic Drugs
Neurol 61:1793-1795, Benbadis,S.R.,et al, 2003
Gabapentin in the Prophylaxis of Chronic Daily Headache
Neurol 61:1753-1759, Spira,P.J.,et al, 2003
Treatment Options for Trigeminal Neuralgia
BMJ 327:1360-1361, Merrison,A.F.A.,et al, 2003
Hyperhomocysteinemia as an Independent Risk Factor for Silent Brain Infarction
Neurol 61:1595-1599, Kim,N.K.,et al, 2003
Clinicopath Conf., Meningencephalitis and Sepsis Due to Neisseria Meningitidis Infection
NEJM 349:2341-2349, Case 38-2003, 2003
Successful Treatment of Hypnic Headache Syndrome with Acetazolamide
Neurol 61:1157-1158, Sibon,I,et al, 2003
Stroke Prevention with the Oral Direct Thrombin Inhibitor Ximelagatran Compared with Warfarin in Patients with Non-Valvular Atrial Fibrillation (SPORTIF III): Randomised Controlled Trial
Lancet 362:1691-1698,1686, Executive Steering Committee on Behalf of the SPOR, 2003
10 Most Commonly Asked Questions About Which Antiplatelet Agent to Prescribe
The Neurologist 9:318-322, Adams,H.P. Jr., 2003
The Use of Mitoxantrone (Novantrone) for the Treatment of Multiple Sclerosis
Neurol 61:1332-1338, Goodin,D.S.,et al, 2003
West Nile Encephalitis
BMJ 326:865-869, Solomon,T.,et al, 2003
Status Epilepticus: A Review of Different Syndromes, Their Current Evaluation, and Treatment
The Neurologist 9:61-76, Gaitanis,J.N. &Drislane,F.W., 2003
Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis
Brain 126:433-437, Filippi,M.,et al, 2003
Smallpox and Smallpox Vaccination
Neurol 60:1241-1245,1228, Booss,J. &Davis,L.E., 2003
Outcome of Trigeminal Nerve Section in the Treatment of Chronic Cluster Headache
Neurol 60:1360-1362, Jarrar,R.G.,et al, 2003
Vaccinations and Risk of Central Nervous System Demyelinating Diseases in Adults
Arch Neurol 60:504-509, DeStefano,F.,et al, 2003
Smallpox, Bioterrorism, and the Neurologist
Arch Neurol 60:489-494, Cleri,D.J.,et al, 2003
Why Headache Treatment Fails
Neurol 60:1064-1070, Lipton,R.B.,et al, 2003
Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter Gene ABCB1
NEJM 348:1442-1448,1480, Siddiqui,A.,et al, 2003
Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 34:1056-1083, Adams,H.P.,et al, 2003
Platelet Function Under Aspirin, Clopidogrel, and Both After Ischemic Stroke
Stroke 34:849-855, Grau,A.J.,et al, 2003
Clinical Relevance of Atrial Fibrillation/Flutter, Stroke, Pacemaker Implant, and Heart Failure in Emery-Dreifuss Muscular Dystrophy
Stroke 34:901-908, Boriani,G.,et al, 2003
Secondary Prevention of Stroke in Italy
Stroke 34:1010-1014, Filippi,A.,et al, 2003
The Emergency Management of Headaches
The Neurologist 9:93-98, Green,M.W., 2003
Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke Among the Elderly
NEJM 348:1322-1332, Nichol,K.L.,et al, 2003
Apoptosis and Caspases in Neurodegenerative Diseases
NEJM 348:1365-1375, Friedlander,R.M., 2003
Blood Pressure-Lowering for Secondary Prevention of Stroke: ACE Inhibition Is Not the Key
Stroke 34:1334-1335,1335, Bath,P., 2003
Blood Pressure--Lowering for Secondary Prevention of Stroke: ACE Inhibition Is the Key
Stroke 34:1333-1334,1334, Anderson,C., 2003
Lamotrigine for HIV-Associated Painful Sensory Neuropathies
Neurol 60:1508-1514, Simpson,D.M.,et al, 2003